XML 23 R8.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Operating Activities      
Net income (loss) $ 2,052 $ 12,531 $ (20,371)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization 78,795 82,232 87,319
Loss on disposal of assets 488 978 2,572
Share-based compensation expense 44,502 39,316 55,300
Deferred income taxes (1,293) (14,855) (11,047)
Amortization of operating lease right-of-use assets 7,839 7,523 8,239
Impairment and abandonment of operating lease right-of-use assets related to facilities 0 0 9,998
Impairment of external-use software development costs 599 0 0
Impairment of certain long-lived assets 0 0 1,014
Inventory write-down 0 5,393 0
Amortization of debt issuance costs 2,651 3,788 4,397
Gain on extinguishment of convertible senior notes, net 0 (7,517) 0
Changes in operating assets and liabilities:      
Accounts receivable and unbilled receivables 41,424 (5,002) 49,150
Inventories (11,225) 15,633 38,016
Prepaid expenses (7,767) 24 1,149
Other current assets (774) 9,337 (6,821)
Investment in sales-type leases (10,171) (10,398) (10,411)
Prepaid commissions 1,816 (2,242) 7,069
Other long-term assets 4,087 2,161 2,111
Accounts payable (9,283) 7,210 (17,525)
Accrued compensation (4,009) 8,553 (21,461)
Accrued liabilities (18,957) 13,942 (10,343)
Deferred revenues 16,379 28,952 24,058
Operating lease liabilities (11,725) (10,737) (10,918)
Other long-term liabilities 1,872 900 (401)
Net cash provided by operating activities 127,300 187,722 181,094
Investing Activities      
Asset acquisition (2,430) 0 0
External-use software development costs (17,518) (16,330) (13,542)
Purchases of property and equipment (40,415) (36,463) (41,474)
Net cash used in investing activities (60,363) (52,793) (55,016)
Financing Activities      
Payments for debt issuance costs for revolving credit facility 0 0 (2,967)
Repayment of convertible senior notes due 2025 (175,000) 0 0
Proceeds from issuance of convertible senior notes, net of issuance costs 0 166,272 0
Partial repurchase of convertible senior notes 0 (391,000) 0
Purchase of convertible note hedge 0 (40,279) 0
Proceeds from sale of warrants 0 25,168 0
Partial unwind of convertible note hedge and warrants 0 (727) 0
Proceeds from issuances under stock-based compensation plans 16,868 13,411 23,216
Employees’ taxes paid related to restricted stock units (7,684) (4,827) (7,366)
Common stock repurchases (77,600) 0 0
Change in customer funds, net 25,099 (3,596) 10,537
Net cash provided by (used in) financing activities (218,317) (235,578) 23,420
Effect of exchange rate changes on cash and cash equivalents 3,798 (1,716) (1,354)
Net increase (decrease) in cash, cash equivalents, and restricted cash (147,582) (102,365) 148,144
Cash, cash equivalents, and restricted cash at beginning of period 398,614 500,979 352,835
Cash, cash equivalents, and restricted cash at end of period 251,032 398,614 500,979
Reconciliation of cash, cash equivalents, and restricted cash to the Consolidated Balance Sheets:      
Cash and cash equivalents 196,520 369,201 467,972
Restricted cash included in other current assets 54,512 29,413 33,007
Cash, cash equivalents, and restricted cash at end of period 251,032 398,614 500,979
Supplemental cash flow information:      
Cash paid for interest 2,201 1,624 1,438
Supplemental disclosure of non-cash investing and financing activities:      
Unpaid purchases of property and equipment 2,271 1,031 877
Excise tax payable on common stock repurchases $ 388 $ 0 $ 0